The Pearl Psychedelic Institute, identified by EIN 85-4272437, is dedicated to advancing the study and understanding of psychedelic medicines through research, treatment, training, and community education, particularly in the areas of brain disorders and health. With an operating budget of $539.5K and total revenue of $630.2K for the filing year 2023, the organization has a diverse funding base and does not rely on a single funder for 50% or more of its revenue. More information about their initiatives can be found on their website, www.pearlpsychedelicinstitute.org.